Fundz

Who to call at FibroBiologics, and when

Fundz watches for the moments FibroBiologics starts buying, and tells you who to reach.

  • An alert the day FibroBiologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at FibroBiologics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Fibro Biologics is looking to raise $10,000

Mar 29, 2023

Target Amount

$10,000

Deadline

Apr 04, 2023

CIK0001958777
File Number007-00007

Issuer Information

Issuer

FibroBiologics

Location

455 e. medical center blvd, suite 300

houston, texas, united states

About

FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.

G2 High Performer Badge

⚡ Your AI Catches Every Buying Signal

While you sleep, we analyze 1,000+ companies across all strategic moves.

Set your ICP once, then wake up to:

• Companies that just hired key executives

• Fresh funding rounds AND acquisitions

• Product launches & new partnerships

• Your top matches from ALL momentum signals

2 to 50 AI-scored leads daily, by plan

Trusted by sales, BD, and investment teams at Oracle, HubSpot, and more.

Campaign Status

Filing TypeRegulation CF (C/A)
Target Amount$10,000
Securities TypeOther

Campaign Ended

Ended 1298 days ago

View SEC Filing

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment FibroBiologics opens a raise, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ruben
Likely contact at this company
••••••••@••••••••

See Ruben's verified email →

Create an account to reveal verified emails

This company raised through a public offering. Fundz reads the filing itself, not a press release.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.